Qiagen (QGEN) Profit Margin (2008 - 2025)
Qiagen (QGEN) profit margin from Dec 31, 2008 to Dec 31, 2025. The current Qiagen (QGEN) profit margin is 20.33%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Annual Profit Margin change of Qiagen (QGEN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 20.33% | +381.10% |
| 2024 | 4.23% | -75.67% |
| 2023 | 17.37% | -12.12% |
| 2022 | 19.76% | -13.19% |
| 2021 | 22.77% | +18.54% |
| 2020 | 19.20% | -807.21% |
| 2019 | -2.72% | -121.42% |
| 2018 | 12.68% | +344.89% |
| 2017 | 2.85% | -52.58% |
| 2016 | 6.01% | -40.86% |
| 2015 | 10.16% | +17.41% |
| 2014 | 8.65% | +63.12% |
| 2013 | 5.30% | -48.61% |
| 2012 | 10.32% | +25.74% |
| 2011 | 8.21% | -38.13% |
| 2010 | 13.27% | -2.73% |
| 2009 | 13.64% | +36.84% |
| 2008 | 9.97% | N/A |
Comparison Qiagen (QGEN) profit margin with competitors
Qiagen (QGEN) profit margin is 20.33%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | +20.07% |
| VCYT | Veracyte Inc | 20.64% | +1.53% |
| A | Agilent Technologies Inc | 18.47% | -9.15% |
| MTD | Mettler-Toledo International Inc | 17.89% | -12.00% |
| MEDP | Medpace Holdings Inc | 17.53% | -13.77% |
| DHR | Danaher Corp | 17.29% | -14.95% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -18.44% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -26.21% |
| ILMN | Illumina Inc | 12.28% | -39.59% |
| SHC | Sotera Health Company | 9.49% | -53.32% |
| DGX | Quest Diagnostics Inc | 8.70% | -57.20% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -61.39% |
| IQV | IQVIA Holdings Inc | 6.60% | -67.53% |
| FONR | Fonar Corp | 6.20% | -69.50% |
| RVTY | Revvity Inc | 5.73% | -71.81% |
| ICLR | Icon Plc | 2.78% | -86.33% |
| CDNA | Caredx Inc | 2.39% | -88.24% |